It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
PLSE’s FA Score shows that 0 FA rating(s) are green whileSTXS’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
PLSE’s TA Score shows that 2 TA indicator(s) are bullish while STXS’s TA Score has 5 bullish TA indicator(s).
PLSE (@Pharmaceuticals: Other) experienced а -0.27% price change this week, while STXS (@Pharmaceuticals: Other) price change was +12.61% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.27%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was +3.27%.
PLSE is expected to report earnings on Aug 12, 2025.
STXS is expected to report earnings on Nov 06, 2025.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
PLSE | STXS | PLSE / STXS | |
Capitalization | 990M | 226M | 438% |
EBITDA | -62.52M | -24.72M | 253% |
Gain YTD | -15.508 | 9.649 | -161% |
P/E Ratio | N/A | N/A | - |
Revenue | 0 | 27.5M | - |
Total Cash | 119M | 10.6M | 1,123% |
Total Debt | 8.58M | 5.87M | 146% |
PLSE | STXS | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 64 Fair valued | 100 Overvalued | |
PROFIT vs RISK RATING 1..100 | 88 | 100 | |
SMR RATING 1..100 | 98 | 100 | |
PRICE GROWTH RATING 1..100 | 82 | 43 | |
P/E GROWTH RATING 1..100 | 100 | 60 | |
SEASONALITY SCORE 1..100 | 85 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PLSE's Valuation (64) in the Medical Specialties industry is somewhat better than the same rating for STXS (100). This means that PLSE’s stock grew somewhat faster than STXS’s over the last 12 months.
PLSE's Profit vs Risk Rating (88) in the Medical Specialties industry is in the same range as STXS (100). This means that PLSE’s stock grew similarly to STXS’s over the last 12 months.
PLSE's SMR Rating (98) in the Medical Specialties industry is in the same range as STXS (100). This means that PLSE’s stock grew similarly to STXS’s over the last 12 months.
STXS's Price Growth Rating (43) in the Medical Specialties industry is somewhat better than the same rating for PLSE (82). This means that STXS’s stock grew somewhat faster than PLSE’s over the last 12 months.
STXS's P/E Growth Rating (60) in the Medical Specialties industry is somewhat better than the same rating for PLSE (100). This means that STXS’s stock grew somewhat faster than PLSE’s over the last 12 months.
PLSE | STXS | |
---|---|---|
RSI ODDS (%) | N/A | 4 days ago83% |
Stochastic ODDS (%) | 4 days ago81% | 4 days ago75% |
Momentum ODDS (%) | 4 days ago82% | 4 days ago86% |
MACD ODDS (%) | 4 days ago90% | 4 days ago81% |
TrendWeek ODDS (%) | 4 days ago85% | 4 days ago83% |
TrendMonth ODDS (%) | 4 days ago87% | 4 days ago82% |
Advances ODDS (%) | 6 days ago85% | 15 days ago77% |
Declines ODDS (%) | 4 days ago85% | 11 days ago81% |
BollingerBands ODDS (%) | 4 days ago79% | 4 days ago78% |
Aroon ODDS (%) | 4 days ago90% | 4 days ago78% |
A.I.dvisor indicates that over the last year, PLSE has been loosely correlated with CERS. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if PLSE jumps, then CERS could also see price increases.
Ticker / NAME | Correlation To PLSE | 1D Price Change % | ||
---|---|---|---|---|
PLSE | 100% | -0.07% | ||
CERS - PLSE | 37% Loosely correlated | -2.42% | ||
VAPO - PLSE | 31% Poorly correlated | N/A | ||
STXS - PLSE | 31% Poorly correlated | +14.16% | ||
CLPT - PLSE | 31% Poorly correlated | +0.28% | ||
TMCI - PLSE | 31% Poorly correlated | +7.92% | ||
More |
A.I.dvisor indicates that over the last year, STXS has been loosely correlated with SMTI. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if STXS jumps, then SMTI could also see price increases.
Ticker / NAME | Correlation To STXS | 1D Price Change % | ||
---|---|---|---|---|
STXS | 100% | +14.16% | ||
SMTI - STXS | 39% Loosely correlated | +1.81% | ||
TWST - STXS | 37% Loosely correlated | +2.56% | ||
PSNL - STXS | 33% Loosely correlated | -0.77% | ||
BLFS - STXS | 33% Poorly correlated | N/A | ||
VCYT - STXS | 33% Poorly correlated | -1.12% | ||
More |